We are live on ! Find out more
HL

Harding Loevner Portfolio holdings

AUM $10.6B
1-Year Est. Return 19.39%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+19.39%
3 Year Est. Return
+79.14%
5 Year Est. Return
+100.61%
10 Year Est. Return
+428.16%
AUM
$13.5B
AUM Growth
+$101M
Cap. Flow
+$252M
Cap. Flow %
1.86%
Top 10 Hldgs %
31.95%
Holding
88
New
3
Increased
33
Reduced
39
Closed
3
Avg Time Held
4.3 quarters
Top 10 Avg Time Held
3.2 quarters
Top 20 Avg Time Held
3.9 quarters

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$166M
2
MA icon
Mastercard
MA
+$139M
3
FRC
First Republic Bank
FRC
+$70.5M
4
TSM icon
TSMC
TSM
+$28.3M
5
CBD
Companhia Brasileira de Distribuicao
CBD
+$24.5M

Top Sells

Rank Stock Value
1
QGENF
QIAGEN NV
QGENF
+$120M
2
WFC icon
Wells Fargo
WFC
+$78.6M
3
PX
Praxair Inc
PX
+$44.7M
4
BG icon
Bunge Global
BG
+$37.9M
5
KOF icon
Coca-Cola Femsa
KOF
+$34.3M

Sector Composition

Rank Sector Weight
1 Financials 22.47%
2 Technology 15.88%
3 Energy 10.63%
4 Consumer Staples 10.15%
5 Healthcare 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MON
26
DELISTED
Monsanto Co
MON
$213M 1.57%
1,890,763
-15,952
-0.8% -$1.87M
2013 Q2
5 quarters
CTXS
27
DELISTED
Citrix Systems Inc
CTXS
$201M 1.49%
3,546,894
-35,954
-1% -$1.96M
2013 Q2
5 quarters
FFIV icon
28
F5
FFIV
$27.2B
$194M 1.44%
1,636,388
-16,638
-1% -$1.95M
2013 Q2
5 quarters
HDB icon
29
HDFC Bank
HDB
$115B
$188M 1.39%
16,180,420
+1,365,924
+9% +$16.6M
2013 Q2
5 quarters
EMR icon
30
Emerson Electric
EMR
$90.3B
$185M 1.37%
2,960,569
-29,935
-1% -$1.94M
2013 Q2
5 quarters
MMM icon
31
3M
MMM
$82.5B
$176M 1.3%
1,487,426
-15,071
-1% -$1.81M
2013 Q2
5 quarters
AMX icon
32
America Movil
AMX
$63.7B
$174M 1.28%
6,889,277
-97,370
-1% -$2.34M
2013 Q2
5 quarters
ABBV icon
33
AbbVie
ABBV
$489B
$173M 1.28%
+2,998,750
New +$166M
2014 Q3
0 quarters
AXP icon
34
American Express
AXP
$208B
$169M 1.25%
1,930,958
+29,989
+2% +$2.7M
2013 Q2
5 quarters
BWA icon
35
BorgWarner
BWA
$12.5B
$166M 1.23%
3,586,437
-33,273
-0.9% -$1.82M
2013 Q2
5 quarters
XOM icon
36
ExxonMobil
XOM
$695B
$162M 1.2%
1,724,152
-18,232
-1% -$1.82M
2013 Q2
5 quarters
IPGP icon
37
IPG Photonics
IPGP
$3.33B
$151M 1.12%
2,191,881
+178,897
+9% +$12.1M
2014 Q2
1 quarter
WPP icon
38
WPP
WPP
$5.47B
$150M 1.11%
1,514,771
+6,659
+0.4% +$690K
2013 Q2
5 quarters
ABT icon
39
Abbott
ABT
$172B
$148M 1.1%
3,559,040
-32,974
-0.9% -$1.39M
2013 Q2
5 quarters
TRMB icon
40
Trimble
TRMB
$14B
$145M 1.08%
4,764,897
-44,425
-0.9% -$1.44M
2013 Q2
5 quarters
CTSH icon
41
Cognizant
CTSH
$26.7B
$138M 1.02%
3,088,545
-27,585
-0.9% -$1.3M
2013 Q2
5 quarters
INFA
42
DELISTED
INFORMATICA CORP
INFA
$130M 0.97%
3,811,712
-33,988
-0.9% -$1.13M
2013 Q2
5 quarters
WAT icon
43
Waters Corp
WAT
$42.6B
$130M 0.96%
1,315,386
-9,830
-0.7% -$1.01M
2014 Q2
1 quarter
BBD icon
44
Banco Bradesco
BBD
$45.5B
$130M 0.96%
23,234,689
+3,237,790
+16% +$20.2M
2013 Q2
5 quarters
PG icon
45
Procter & Gamble
PG
$351B
$129M 0.95%
1,540,312
-11,872
-0.8% -$973K
2013 Q2
5 quarters
PX
46
DELISTED
Praxair Inc
PX
$123M 0.91%
950,812
-341,177
-26% -$44.7M
2013 Q2
5 quarters
BAP icon
47
Credicorp
BAP
$30.3B
$117M 0.86%
760,071
+144,265
+23% +$22.1M
2013 Q2
5 quarters
CBD
48
DELISTED
Companhia Brasileira de Distribuicao
CBD
$115M 0.85%
2,628,415
+508,095
+24% +$24.5M
2013 Q4
3 quarters
NVO
49
Novo Nordisk
NVO
$171B
$115M 0.85%
4,800,182
+756,910
+19% +$17.4M
2013 Q2
5 quarters
RL icon
50
Ralph Lauren
RL
$22.1B
$114M 0.84%
691,424
-4,987
-0.7% -$821K
2013 Q2
5 quarters
1
2
3 4

Similar funds

FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
VAS
Vestmark Advisory Solutions Wakefield, Massachusetts $10.6B AUM 25.02% 1-Year Est. Return
DPIM
Duff & Phelps Investment Management Chicago, Illinois $10.6B AUM 18.62% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $10.5B AUM 42.22% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $10.5B AUM 37.62% 1-Year Est. Return

Harding Loevner's Q3 2014 Portfolio in Review

As of Q3 2014, Harding Loevner held 88 positions worth $13.5B, up 0.75% from $13.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Harding Loevner's Q3 2014 filing shows 3 new, 33 increased, 39 reduced and 3 closed positions. Its largest new stake was AbbVie: 2,998,750 shares worth $173M. The largest sale was QIAGEN NV, an estimated $120M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Energy.

  • Harding Loevner's largest Q3 2014 buy was AbbVie: 2,998,750 shares worth $173M.
  • Harding Loevner added most to Mastercard in Q3 2014, an estimated $139M increase.
  • Harding Loevner's biggest Q3 2014 reduction was QIAGEN NV, cutting an estimated $120M.
  • Harding Loevner fully exited Coca-Cola Femsa in Q3 2014, selling an estimated $34.3M.
  • Harding Loevner's ten largest holdings make up 32% of its $13.5B portfolio in Q3 2014.
  • Harding Loevner opened 3 new positions and closed 3 in Q3 2014.
  • Harding Loevner's portfolio value rose 0.75% quarter-over-quarter to $13.5B.

Based on Harding Loevner's 13F filing for Q3 2014, filed 31 Oct 2014.